Tiao-Lai Huang Selected Research

Clozapine (Clozaril)

10/2018	Excited catatonia in a patient with fatal pulmonary embolism and a successful treatment strategy.
1/2017	Periodic catatonia with long-term treatment: a case report.
4/2016	Relapses and recurrences of catatonia: 30-case analysis and literature review.
10/2011	Effects of antipsychotics on the serum BDNF levels in schizophrenia.
1/2007	Correlations between weight changes and lipid profile changes in schizophrenic patients after antipsychotics therapy.
11/2006	Clozapine for blepharospasm, obsessive-compulsive symptoms, and psychotic symptoms in a patient of old brain infarction.
4/2006	Clozapine in schizophrenia patients with recurrent catatonia: report of two cases.
7/2004	Massive pulmonary embolism in a young patient on clozapine therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tiao-Lai Huang Research Topics

Disease

29	Schizophrenia (Dementia Praecox) 01/2022 - 12/2002
19	Major Depressive Disorder (Major Depressive Disorders) 01/2022 - 05/2003
13	Catatonia 10/2018 - 02/2005
7	Mania (Manias) 01/2019 - 08/2002
6	Bipolar Disorder (Manic Depressive Psychosis) 01/2022 - 03/2007
6	Inflammation (Inflammations) 01/2017 - 01/2005
3	Mental Disorders (Mental Disorder) 01/2022 - 04/2004
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2017 - 11/2010
3	Mood Disorders (Mood Disorder) 01/2017 - 08/2002
3	Body Weight (Weight, Body) 01/2015 - 08/2002
2	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2022 - 01/2017
2	Psychotic Disorders (Schizoaffective Disorder) 10/2018 - 04/2004
2	Depressive Disorder (Melancholia) 05/2006 - 06/2004
1	Narcolepsy 01/2022
1	Sleep Wake Disorders 01/2022
1	Weight Gain 01/2022
1	Polydipsia 01/2022
1	Alcoholism (Alcohol Abuse) 04/2020
1	Opioid-Related Disorders (Opiate Addiction) 07/2019
1	Hallucinations (Hallucination) 10/2018
1	Parkinson Disease (Parkinson's Disease) 03/2018
1	Heroin Dependence (Heroin Abuse) 03/2017
1	Brain Injuries (Brain Injury) 01/2017
1	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 01/2017
1	Glycogen Storage Disease Type VI (Glycogenosis Type VI) 01/2017
1	Leukemia 09/2016
1	Dry Eye Syndromes (Dry Eye Syndrome) 01/2013
1	Albuminuria 01/2013
1	Breast Neoplasms (Breast Cancer) 01/2013
1	Ischemic Stroke 01/2013
1	Type 2 Diabetes Mellitus (MODY) 10/2012
1	Paranoid Schizophrenia (Delusional Disorder) 10/2011

Drug/Important Bio-Agent (IBA)

19	Brain-Derived Neurotrophic Factor (BDNF)IBA 04/2020 - 10/2006
15	Lorazepam (Ativan)FDA LinkGeneric 10/2018 - 04/2004
15	Antipsychotic Agents (Antipsychotics)IBA 01/2017 - 04/2004
12	Biomarkers (Surrogate Marker)IBA 04/2020 - 05/2006
11	Diazepam (Valium)FDA LinkGeneric 10/2018 - 02/2005
10	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2006
8	Clozapine (Clozaril)FDA LinkGeneric 10/2018 - 07/2004
8	LipidsIBA 01/2015 - 05/2003
7	Messenger RNA (mRNA)IBA 01/2020 - 12/2014
6	Antidepressive Agents (Antidepressants)IBA 12/2018 - 04/2004
4	Nerve Growth Factors (Neurotrophins)IBA 01/2020 - 01/2015
3	Blood Proteins (Serum Proteins)IBA 01/2022 - 01/2012
3	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2017 - 12/2014
3	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2017 - 10/2011
3	TropomyosinIBA 05/2013 - 05/2010
3	Phosphotransferases (Kinase)IBA 05/2013 - 05/2010
3	CholesterolIBA 05/2006 - 01/2005
3	oxidized low density lipoproteinIBA 05/2006 - 05/2003
2	Paroxetine (Paxil)FDA LinkGeneric 01/2022 - 01/2022
2	Glutathione PeroxidaseIBA 04/2020 - 10/2013
2	DefensinsIBA 10/2017 - 01/2013
2	Haloperidol (Haldol)FDA LinkGeneric 01/2017 - 09/2010
2	CatalaseIBA 01/2016 - 10/2013
2	Superoxide DismutaseIBA 01/2016 - 10/2013
2	Thiobarbituric Acid Reactive SubstancesIBA 10/2013 - 05/2010
2	C-Reactive ProteinIBA 06/2013 - 03/2007
2	AlbuminsIBA 01/2013 - 08/2002
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2011 - 08/2007
2	HDL LipoproteinsIBA 11/2010 - 12/2005
2	BenzodiazepinesIBA 12/2006 - 04/2006
2	LDL Lipoproteins (beta Lipoproteins)IBA 12/2005 - 05/2003
2	Lipoproteins (Lipoprotein)IBA 06/2004 - 05/2003
2	Serum AlbuminIBA 12/2002 - 08/2002
1	OrexinsIBA 01/2022
1	Methadone (Dolophine)FDA LinkGeneric 07/2019
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 07/2019
1	RNA (Ribonucleic Acid)IBA 07/2019
1	MicroRNAs (MicroRNA)IBA 07/2019
1	Opioid Analgesics (Opioids)IBA 07/2019
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2017
1	Quetiapine Fumarate (Seroquel)FDA Link 01/2017
1	Phosphopyruvate Hydratase (Enolase)IBA 01/2017
1	Loxapine (Loxitane)FDA LinkGeneric 01/2017
1	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 01/2017
1	AcidsIBA 12/2016
1	Immunoglobulin G (IgG)IBA 12/2016
1	Lysine (L-Lysine)FDA Link 09/2016
1	Histones (Histone)IBA 09/2016
1	histone H3 trimethyl Lys4IBA 09/2016
1	Toll-Like Receptor 4IBA 01/2015
1	Indicators and Reagents (Reagents)IBA 12/2013
1	Glutathione (Reduced Glutathione)IBA 10/2013
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 06/2013
1	Peptides (Polypeptides)IBA 01/2013
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2013
1	GlobinsIBA 01/2013
1	trimethylamineIBA 01/2013
1	Hemoglobins (Hemoglobin)IBA 01/2013
1	Mitochondrial DNA (mtDNA)IBA 10/2012

Therapy/Procedure

3	Intramuscular Injections 09/2010 - 04/2004
3	Renal Dialysis (Hemodialysis) 09/2008 - 01/2007
2	Therapeutics 07/2019 - 07/2004
2	Lasers (Laser) 10/2017 - 12/2016
2	Aftercare (After-Treatment) 01/2017 - 10/2013
1	Transcranial Direct Current Stimulation 01/2022
1	Transcranial Magnetic Stimulation 01/2022
1	Vagus Nerve Stimulation 01/2022
1	Deep Brain Stimulation 03/2018